1. Burki T. Tuberculosis control: getting back on track in the era of COVID-19. Lancet Respir Med. 2022 Dec;10(12):e112. https://doi.org/10.1016/s2213-2600(22)00442-8. [ DOI] [ PubMed] 2. Dzinamarira T, Moyo E, Moyo P, Pierre G, Mpabuka E, Kahere M, et al. Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa. J Infect. 2022 Oct;85(4):436-80. https://doi.org/10.1016/j.jinf.2022.07.020. [ DOI] [ PubMed] 3. Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021 Dec;113(1):S7-S12. https://doi.org/10.1016/j.ijid.2021.02.107. [ DOI] [ PubMed] 4. Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022 Jun;10(6):603-22. https://doi.org/10.1016/s2213-2600(22)00092-3. [ DOI] [ PubMed] 5. McArdle AJ, Turkova A, Cunnington AJ. When do co-infections matter? Curr Opin Infect Dis. 2018 Jun;31(3):209-15. https://doi.org/10.1097/qco.0000000000000447. [ DOI] [ PubMed] 6. WHO. Impact of the COVID-19 pandemic on TB detection and mortality in 2020. 2021 March. [ Link] 7. Chakaya J, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, et al. The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB. International Journal of Infectious Diseases (IJID). 2022 Nov; 124(1): S26-S29. https://doi.org/10.1016/j.ijid.2022.03.011. [ Link] [ DOI] 8. Sarkar S, Khanna P, Singh AK. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses. J Med Virol. 2021 Apr;93(4):2385-95. https://doi.org/10.1002/jmv.26740. [ DOI] [ PubMed] 9. Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis. PLoS One. 2021 Oct;16(10):e0259006. https://doi.org/10.1371/journal.pone.0259006. [ DOI] [ PubMed] 10. Babamahmoodi F, Anvari F, Alikhani A, Akbari Z, Ahangarkani F. [Clinical Epidemiology of Hospitalized Patients with Tuberculosis and COVID 19 Co-infection in Qaemshahr Razi Teaching Hospital, 2020-2022]. J Mazandaran Univ Med Sci. 2023;32(217):96-104. [Article in Persian] [ Link] 11. Lv J, Liang M, Wang L, Zhang M, Liu R, Liang H, et al. Clinical characteristics and outcomes of patients with COVID-19 and tuberculosis coinfection. Infect Dis (Lond). 2023 Dec;55(12):839-46. https://doi.org/10.1080/23744235.2023.2245885. [ DOI] [ PubMed] 12. Brogan M, Ross MJ. The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit. Nephron. 2022;146(1):67-71. https://doi.org/10.1159/000519530. [ DOI] [ PubMed] 13. Zheng B, Daines L, Han Q, Hurst JR, Pfeffer P, Shankar-Hari M, et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. Eur Respir Rev. 2022 Nov 2;31(166):220071. https://doi.org/10.1183/16000617.0071-2022. [ DOI] [ PubMed] 14. Fernández-Villar A, Sopeña B, Fernández-Villar J, Vázquez-Gallardo R, Ulloa F, Leiro V, et al. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. Int J Tuberc Lung Dis. 2004 Dec;8(12):1499-505. [ PubMed] 15. Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, et al. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021 Mar-Apr;21:100267. https://doi.org/10.1016/j.aohep.2020.09.011. [ DOI] [ PubMed] 16. Kalyesubula R, Wearne N, Kubo M, Hussey N, Naicker S. HIV and Associated TB: A Lethal Association for Kidney Health? Semin Nephrol. 2023 Sep;43(5):151470. https://doi.org/10.1016/j.semnephrol.2023.151470. [ DOI] [ PubMed] 17. Xu Z, Zhang Y, Zhang C, Xiong F, Zhang J, Xiong J. Clinical Features and Outcomes of COVID-19 Patients with Acute Kidney Injury and Acute Kidney Injury on Chronic Kidney Disease. Aging Dis. 2022 Jun;13(3):884-98. https://doi.org/10.14336/ad.2021.1125. [ DOI] [ PubMed] 18. Kouhsari E, Sadeghifard N, Karimian M, Kalvandi G, Sayyadi H, Feizi J, et al. The Effectiveness of Laboratory Parameters in Predicting the in-Hospital Mortality of Iranian Patients with Coronavirus Disease 2019 (COVID-19). Ann Ig. 2022 Mar-Apr;34(2):128-36. https://doi.org/10.7416/ai.2022.2475. [ DOI] [ PubMed] 19. Mahfoozi L, Haghighi M, Rezaei S, Karimian P. [The Relationship of Some Liver Function Tests and Red Blood Cell Parameters With Disease Outcome of Patients With COVID-19 Admitted to Razi Hospital, Rasht, Northern Iran]. JGUMS. 2025;34(1):70-79. [Article in Persian] http://dx.doi.org/10.32598/JGUMS.34.1.2031.1. [ Link] [ DOI] 20. Gao Y, Liu M, Chen Y, Shi S, Geng J, Tian J. Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis. J Med Virol. 2021 Jan;93(1):194-96. https://doi.org/10.1002/jmv.26311. [ DOI] [ PubMed] 21. Koupaei M, Naimi A, Moafi N, Mohammadi P, Tabatabaei FS, Ghazizadeh S, et al. Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review. Front Med (Lausanne). 2021 Dec;8:740593. https://doi.org/10.3389/fmed.2021.740593. [ DOI] [ PubMed] 22. Hazra D, Siddalingaiah N, Gupta N, Chawla K, Prabhu AR, Datta D, et al. COVID-19 and tuberculosis coinfection: A case-control study from a tertiary care center in South India. J Family Med Prim Care. 2023 Dec;12(12):3200-203. https://doi.org/10.4103/jfmpc.jfmpc_791_23. [ DOI] [ PubMed] 23. Kashi P, Pakdel F, Barhaghi MHS, Rezaee MA, Taghizadeh S, Sadeghi J, et al. Genetic diversity of Mycobacterium tuberculosis isolates from northwest of Iran during COVID-19 era. Egypt J Med Hum Genet. 2023;24(1):3. https://doi.org/10.1186/s43042-023-00383-4. [ DOI] [ PubMed] |
